Experimental stem cells tested for ALS in one patient
NCT ID NCT04514952
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 24 times
Summary
This study tested a stem cell treatment for one person with ALS, a progressive nerve disease. The treatment used the patient's own fat-derived stem cells to try to control the disease. The study is no longer available for new participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
River Oaks Hospital and Clinics
Houston, Texas, 77027, United States
Conditions
Explore the condition pages connected to this study.